The metabolic effects of short-term administration of physiological versus high doses of GH therapy in GH deficient adults

Clinical Endocrinology

Volumn 57, Issue 3, 2002, Pages 333-341

  Yuen, K ^a   Cook, D ^b   Ong, K ^a   Chatelain, P ^c   Fryklund, L ^c   Gluckman, P ^d   Ranke, M B ^e   Rosenfeld, R ^b   Dunger, D ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c Pharmacia Corporation   (Sweden)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

^e UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GROWTH HORMONE; INSULIN; SEX HORMONE; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN C; TESTOSTERONE;

ADULT; ARTICLE; B LYMPHOCYTE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG EFFECT; FEMALE; GROWTH HORMONE DEFICIENCY; HOMEOSTASIS; HUMAN; HYPOPITUITARISM; INSULIN SENSITIVITY; MALE; PHYSIOLOGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; BLOOD GLUCOSE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMAN GROWTH HORMONE; HUMANS; HYPOPITUITARISM; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 0036042655     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2002.01601.x     Document Type: Article

References (51)

1. On the diabetogenic effect of growth hormone in man: Effects of growth hormone of glucagon and insulin secretion
2. Insulin-like and diabetogenic effects of growth hormone in healthy subjects, diabetics, and low insulin responders
3. Abnormal body composition and reduced bone mass in growth hormone deficient hypopituitary adults
4. The effects of short- and long-term growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance
5. Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 (IGFBP-3) reflect spontaneous growth hormone secretion
6. Clinical aspects of growth hormone deficiency in adults
7. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: Studies in subjects with various degrees of glucose tolerance and insulin sensitivity
8. Relations between immunoreactive somatomedin C, insulin and T3 patterns during fasting in obese subjects
9. Effects of insulin and growth hormone on the flux rates of plasma glucose and plasma free fatty acids in man
10. Defects of insulin action and skeletal muscle glucose metabolism in growth hormone deficient adults persist after 24 months of recombinant human growth hormone therapy
11. The relationship between insulin-like growth factor-1, adiposity, and aging
12. Induction of immunoreactive somatomedin C in human serum by growth hormone: Dose-response relationship an effect on chromatographic profiles
13. Acute metabolic effects of human growth hormone
14. Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency
15. Free insulin-like growth factors in human obesity
16. Dose-response study of GH effects on circulating IGF-1 and IGFBP-3 levels in healthy young men and women
17. Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: Summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency
18. Insulin resistance, body fat distribution and sex hormones in man
19. The homeostasis model in the San Antonio Heart Study
20. Risk and mechanism of dexamethasone induced deterioration of glucose tolerance in non-diabetic first-degree relatives of NIDDM patients
21. Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes
22. Insulin resistance in growth hormone deficient adults: Defects in glucose utilisation and glycogen synthase activity
23. Effects of sex and age on the 24-hour profile of growth hormone secretion in man: Importance of endogenous estradiol concentrations
24. Growth hormone (GH) replacement reduces total body fat and normalizes insulin sensitivity in GH-deficient adults: A report of one-year clinical experience
25. Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men
26. A low starting dose of genotropin in growth hormone-deficient adults
27. Growth hormone-deficient adults are insulin-resistant
28. Beneficial effects of growth hormone treatment in GH-deficient adults
29. The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, -2 and -3) decreases with age in healthy adults and is increased in acromegalic patients
30. Correct homeostasis model assessment (HOMA) evaluation uses the computer program
31. Effects of short-term administration of low-dose rhGH on IGF-I levels in obesity and Cushing's syndrome: Indirect evaluation of sensitivity to GH
32. Physiological concentrations of growth hormone exert insulin-like and insulin antagonistic effects on both hepatic and extrahepatic tissues in man
33. Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man
34. The effects on insulin action in adult hypopituitarism of recombinant human GH therapy individually titrated for six months
35. Effects of low-dose oral hydrocortisone replacement versus short-term reproduction of physiological serum cortisol concentrations on insulin action in adult-onset hypopituitarism
36. Regulation of β-cell mass by hormones and growth factors
37. The effect of 3 months of recombinant human growth hormone (GH) therapy on insulin and glucose-mediated glucose disposal and insulin secretion in GH-deficient adults: A minimal model analysis
38. Comparison of the effects of oral and transdermal estrogen replacement on insulin sensitivity in post-menopausal women
39. Insulin secretion, insulin sensitivity and glucose-mediated glucose disposal in thyrotoxicosis: A minimal model analysis
40. The glucose fatty acid cycle: Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus
41. Premature mortality due to cardiovascular diseases in hypopituitarism
42. The effect of the deterioration of insulin sensitivity on beta cell function in growth-hormone-deficient adults following four-month growth hormone replacement therapy
43. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency
44. Glucose metabolism and fuel oxidation in lean and obese adults with growth hormone deficiency
45. Effects of growth hormone in vitro on the glucose metabolism of fetal rat islet?-cells
46. An amplitude-specific divergence in the pulsatile mode of growth hormone secretion underlies the gender difference in mean growth hormone concentrations in men and premenopausal women
47. Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man
48. The effect of low dose recombinant human growth hormone on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults
49. Relationship between age, percentage body fat, fitness, and 24-hour growth hormone release in healthy young adults: Effects of gender
50. Relationship between plasma insulin-like growth factor I (IGF-I) levels and body mass index (BMI) in adults
51. The effects of short-term administration of two low doses versus the standard growth hormone replacement dose on insulin sensitivity and fasting glucose levels in young healthy adults